Skip to main content
. 2008 Oct 23;150(3):1330–1340. doi: 10.1210/en.2008-0936

Table 5.

Distal femoral trabecular volume fraction

Strain Treatment BV (mm3)a
TV (mm3)b
BV/TV (%)c
Average P value Average P value Average P value
B6 Control 0.149 ± 0.009 0.794 2.03 ± 0.06 0.789 6.6 ± 0.4 0.170
Rosi 0.153 ± 0.008 2.05 ± 0.05 7.4 ± 0.3
C3H Control 0.641 ± 0.024 0.075 1.45 ± 0.04 0.004 44.2 ± 1.6 0.001
Rosi 0.573 ± 0.027 1.65 ± 0.04 35.1 ± 1.7
DBA Control 0.085 ± 0.007 0.279 1.57 ± 0.02 0.001 5.3 ± 0.4 0.649
Rosi 0.097 ± 0.007 1.72 ± 0.02 5.6 ± 0.4
A/J Control 0.175 ± 0.023 0.834 1.72 ± 0.03 0.010 10.3 ± 1.1 0.361
Rosi 0.167 ± 0.023 1.85 ± 0.03 8.8 ± 1.1
Strain × Rosi 0.2547 0.0255 < 0.0001

Rosi, Rosiglitazone. 

a

Femur length was a significant covariate for DBA/2J only. 

b

Body weight was a significant covariate for C3H/HeJ and DBA/2J. Femur length was also a significant covariate for C3H/HeJ. 

c

Body weight was a significant covariate for C57BL/6J and A/J. The interaction term of body weight × treatment was also a significant covariate for C57BL/6J. Femur length was a significant covariate for DBA/2J only.